Steve Kirberger joined NAMSA in March 2025, following the acquisition of WuXi AppTec’s U.S. Medical Device Testing operations. He had been with WuXi AppTec’s Analytical Chemistry department in St. Paul, Minn., since 2020. Dr. Kirberger primarily analyzes extractables and leachables data of medical device extracts using liquid chromatography/mass spectrometry (LC-MS) and gas chromatography/mass spectrometry (GC-MS) techniques. Prior to working for WuXi AppTec, he received his Ph.D. from the University of Minnesota studying biological systems using synthetic fluorine-containing probe molecules and fluorine-labeled proteins. He also has post-doctoral experience in a protein engineering laboratory and previous industry experience developing formulations for infection prevention.